{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:59:04Z","timestamp":1791093544208,"version":"4.1.0"},"reference-count":95,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T00:00:00Z","timestamp":1390521600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0086073","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T21:33:29Z","timestamp":1390599209000},"page":"e86073","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":46,"title":["Characterization of Glycolytic Enzymes - rAldolase and rEnolase of Leishmania donovani, Identified as Th1 Stimulatory Proteins, for Their Immunogenicity and Immunoprophylactic Efficacies against Experimental Visceral Leishmaniasis"],"prefix":"10.1371","volume":"9","author":[{"given":"Reema","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vikash","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pramod Kumar","family":"Kushawaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandradev Pati","family":"Tripathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amogh Anant","family":"Sahasrabuddhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalyan","family":"Mitra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad Imran","family":"Siddiqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradha","family":"Dube","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2014,1,24]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1084\/jem.174.6.1549","article-title":"Macrophage deactivation by interleukin 10","volume":"174","author":"C Bogdan","year":"1991","journal-title":"J Exp Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1086\/605895","article-title":"CXC chemokine-mediated protection against visceral leishmaniasis: involvement of the proinflammatory response","volume":"200","author":"G Gupta","year":"2009","journal-title":"J Infect Dis"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1128\/IAI.66.5.2135-2142.1998","article-title":"Cloning of Syrian hamster (Mesocricetus auratus) cytokine cDNAs and analysis of cytokine mRNA expression in experimental visceral leishmaniasis","volume":"66","author":"PC Melby","year":"1998","journal-title":"Infect Immun"},{"key":"ref4","first-page":"439","article-title":"Animal models for vaccine studies for visceral leishmaniasis","volume":"123","author":"R Garg","year":"2006","journal-title":"Indian J Med Res"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1128\/IAI.01739-07","article-title":"Vaccination route that induces transforming growth factor beta production fails to elicit protective immunity against Leishmania donovani infection","volume":"77","author":"S Bhowmick","year":"2009","journal-title":"Infect Immun"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"Kumari S, Samant M, Misra P, Khare P, Sisodia B, <etal>et al<\/etal>.. (2008) Th1-stimulatory polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1 kDa offers long-lasting protection against experimental visceral leishmaniasis. Vaccine.","DOI":"10.1016\/j.vaccine.2008.08.021"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.imbio.2007.10.002","article-title":"Protective effect and granuloma down-modulation promoted by RP44 antigen a fructose 1,6 bisphosphate aldolase of Schistosoma mansoni","volume":"213","author":"HH Marques","year":"2008","journal-title":"Immunobiology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/PL00000910","article-title":"Multifunctional alpha-enolase: its role in diseases","volume":"58","author":"V Pancholi","year":"2001","journal-title":"Cell Mol Life Sci"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.molbiopara.2007.11.011","article-title":"Fasciola hepatica leucine aminopeptidase, a promising candidate for vaccination against ruminant fasciolosis","volume":"158","author":"D Acosta","year":"2008","journal-title":"Mol Biochem Parasitol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1128\/IAI.70.2.851-858.2002","article-title":"Onchocerca volvulus glycolytic enzyme fructose-1,6-bisphosphate aldolase as a target for a protective immune response in humans","volume":"70","author":"JS McCarthy","year":"2002","journal-title":"Infect Immun"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S003118209900431X","article-title":"Characterization, cloning and immunogenicity of antigens released by lung-stage larvae of Schistosoma mansoni","volume":"6)","author":"R Harrop","year":"1999","journal-title":"Parasitology 118 (Pt"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1111\/j.1365-2249.2004.02628.x","article-title":"Glycolytic enzymes associated with the cell surface of Streptococcus pneumoniae are antigenic in humans and elicit protective immune responses in the mouse","volume":"138","author":"E Ling","year":"2004","journal-title":"Clin Exp Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.4049\/jimmunol.144.4.1497","article-title":"Specificity and inhibitory activity of antibodies to Plasmodium falciparum aldolase","volume":"144","author":"IK Srivastava","year":"1990","journal-title":"J Immunol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1086\/375356","article-title":"Identification of immunoreactive proteins during acute human giardiasis","volume":"187","author":"JE Palm","year":"2003","journal-title":"J Infect Dis"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"13526","DOI":"10.1073\/pnas.0803195105","article-title":"Synthetic glycopeptide vaccines combining beta-mannan and peptide epitopes induce protection against candidiasis","volume":"105","author":"H Xin","year":"2008","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0166-6851(00)00269-3","article-title":"Interaction of Leishmania mexicana promastigotes with the plasminogen-plasmin system","volume":"110","author":"L Avilan","year":"2000","journal-title":"Mol Biochem Parasitol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00436-002-0688-2","article-title":"Interaction of different Leishmania mexicana morphotypes with plasminogen","volume":"88","author":"M Calcagno","year":"2002","journal-title":"Parasitol Res"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.yexmp.2005.06.005","article-title":"A study of cutaneous lesions caused by Leishmania mexicana in plasminogen-deficient mice","volume":"80","author":"J Maldonado","year":"2006","journal-title":"Exp Mol Pathol"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"5500","DOI":"10.1128\/IAI.00551-07","article-title":"Protective properties and surface localization of Plasmodium falciparum enolase","volume":"75","author":"I Pal-Bhowmick","year":"2007","journal-title":"Infect Immun"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1080\/13693780310001644653","article-title":"Immunogenicity and protective effect of recombinant enolase of Candida albicans in a murine model of systemic candidiasis","volume":"42","author":"C Montagnoli","year":"2004","journal-title":"Med Mycol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1074\/mcp.M500243-MCP200","article-title":"Decoding serological response to Candida cell wall immunome into novel diagnostic, prognostic, and therapeutic candidates for systemic candidiasis by proteomic and bioinformatic analyses","volume":"5","author":"A Pitarch","year":"2006","journal-title":"Mol Cell Proteomics"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1099\/jmm.0.05060-0","article-title":"Binding of Candida albicans enolase to plasmin(ogen) results in enhanced invasion of human brain microvascular endothelial cells","volume":"52","author":"AY Jong","year":"2003","journal-title":"J Med Microbiol"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.vaccine.2004.07.045","article-title":"Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings","volume":"23","author":"O Finco","year":"2005","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1574-6968.2009.01551.x","article-title":"Immunization with SsEno fails to protect mice against challenge with Streptococcus suis serotype 2","volume":"294","author":"M Esgleas","year":"2009","journal-title":"FEMS Microbiol Lett"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1046\/j.1462-5822.2003.00344.x","article-title":"Enolase from Streptococcus sobrinus is an immunosuppressive protein","volume":"6","author":"I Veiga-Malta","year":"2004","journal-title":"Cell Microbiol"},{"key":"ref26","first-page":"79","article-title":"Application of yeast enolase as antigen for immunodiagnosis of malaria","volume":"31","author":"K Sato","year":"2000","journal-title":"Southeast Asian J Trop Med Public Health"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1365-2249.2005.02745.x","article-title":"Immunostimulatory cellular responses of cured Leishmania-infected patients and hamsters against the integral membrane proteins and non-membranous soluble proteins of a recent clinical isolate of Leishmania donovani","volume":"140","author":"R Garg","year":"2005","journal-title":"Clin Exp Immunol"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00436-005-1339-1","article-title":"Refractoriness to the treatment of sodium stibogluconate in Indian kala-azar field isolates persist in in vitro and in vivo experimental models","volume":"96","author":"A Dube","year":"2005","journal-title":"Parasitol Res"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/pmic.200600725","article-title":"Proteomic approach for identification and characterization of novel immunostimulatory proteins from soluble antigens of Leishmania donovani promastigotes","volume":"7","author":"SK Gupta","year":"2007","journal-title":"Proteomics"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0021-9258(19)52451-6","article-title":"Protein measurement with the Folin phenol reagent","volume":"193","author":"OH Lowry","year":"1951","journal-title":"J Biol Chem"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.exppara.2007.01.008","article-title":"Leishmania mexicana: Molecular cloning and characterization of enolase","volume":"116","author":"W Quinones","year":"2007","journal-title":"Exp Parasitol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1042\/bj0630094","article-title":"Carbohydrate metabolism in citric acid fermentation. 4. Purification and properties of aldolase from Aspergillus niger","volume":"63","author":"V Jagannathan","year":"1956","journal-title":"Biochem J"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1110\/ps.8.2.291","article-title":"Crystal structure of human muscle aldolase complexed with fructose 1,6-bisphosphate: mechanistic implications","volume":"8","author":"A Dalby","year":"1999","journal-title":"Protein Sci"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1006\/jmbi.2000.3910","article-title":"Structures of type 2 peroxisomal targeting signals in two trypanosomatid aldolases","volume":"300","author":"DM Chudzik","year":"2000","journal-title":"J Mol Biol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S0022-2836(03)00752-6","article-title":"The crystal structure of Trypanosoma brucei enolase: visualisation of the inhibitory metal binding site III and potential as target for selective, irreversible inhibition","volume":"331","author":"MT da Silva Giotto","year":"2003","journal-title":"J Mol Biol"},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, <etal>et al<\/etal>.. (2006) Comparative protein structure modeling using Modeller. Curr Protoc Bioinformatics Chapter 5: Unit 5 6.","DOI":"10.1002\/0471250953.bi0506s15"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/0035-9203(93)90267-T","article-title":"Cutaneous leishmaniasis due to Leishmania tropica in Jordan","volume":"87","author":"E Saliba","year":"1993","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1002\/jcc.20084","article-title":"UCSF Chimera\u2013a visualization system for exploratory research and analysis","volume":"25","author":"EF Pettersen","year":"2004","journal-title":"J Comput Chem"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"6417","DOI":"10.4049\/jimmunol.1102081","article-title":"Elongation Factor-2, a Th1 Stimulatory Protein of Leishmania donovani, Generates Strong IFN-gamma and IL-12 Response in Cured Leishmania-Infected Patients\/Hamsters and Protects Hamsters against Leishmania Challenge","volume":"187","author":"PK Kushawaha","year":"2011","journal-title":"J Immunol"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.4049\/jimmunol.141.7.2407","article-title":"Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production","volume":"141","author":"AH Ding","year":"1988","journal-title":"J Immunol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.0900265","article-title":"Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-Type immunoprotective response against experimental visceral leishmaniasis","volume":"183","author":"M Samant","year":"2009","journal-title":"J Immunol"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"Singh N, Gupta R, Jaiswal AK, Sundar S, Dube A (2009) Transgenic Leishmania donovani clinical isolates expressing green fluorescent protein constitutively for rapid and reliable ex vivo drug screening. J Antimicrob Chemother.","DOI":"10.1093\/jac\/dkp206"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.4049\/jimmunol.166.3.1912","article-title":"The hamster as a model of human visceral leishmaniasis: progressive disease and impaired generation of nitric oxide in the face of a prominent Th1-like cytokine response","volume":"166","author":"PC Melby","year":"2001","journal-title":"J Immunol"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.1016\/j.vaccine.2005.12.053","article-title":"Leishmania donovani: identification of stimulatory soluble antigenic proteins using cured human and hamster lymphocytes for their prophylactic potential against visceral leishmaniasis","volume":"24","author":"R Garg","year":"2006","journal-title":"Vaccine"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"D854","DOI":"10.1093\/nar\/gkp1004","article-title":"The immune epitope database 2.0","volume":"38","author":"R Vita","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"ref46","first-page":"1248","article-title":"Evolution of Aldolase","volume":"23","author":"WJ Rutter","year":"1964","journal-title":"Fed Proc"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0968-0004(92)90247-7","article-title":"Fructose-bisphosphate aldolases: an evolutionary history","volume":"17","author":"JJ Marsh","year":"1992","journal-title":"Trends Biochem Sci"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.0022-202x.2001.00038.x","article-title":"Leishmaniasis as an emerging infection","volume":"6","author":"CM Choi","year":"2001","journal-title":"J Investig Dermatol Symp Proc"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"10826","DOI":"10.1016\/S0021-9258(18)82060-9","article-title":"Differential usage of the carboxyl-terminal region among aldolase isozymes","volume":"268","author":"L Berthiaume","year":"1993","journal-title":"J Biol Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"4794","DOI":"10.4049\/jimmunol.144.12.4794","article-title":"Macrophage killing of Leishmania parasite in vivo is mediated by nitric oxide from L-arginine","volume":"144","author":"FY Liew","year":"1990","journal-title":"J Immunol"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"871","DOI":"10.4269\/ajtmh.2005.73.871","article-title":"A phase II dose-increasing study of sitamaquine for the treatment of visceral leishmaniasis in Kenya","volume":"73","author":"MK Wasunna","year":"2005","journal-title":"Am J Trop Med Hyg"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.molbiopara.2009.09.001","article-title":"Genetic validation of aldolase and glyceraldehyde-3-phosphate dehydrogenase as drug targets in Trypanosoma brucei","volume":"169","author":"AJ Caceres","year":"2009","journal-title":"Mol Biochem Parasitol"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1099\/mic.0.2008\/017145-0","article-title":"Isolation and characterization of alpha-enolase, a novel fibronectin-binding protein from Streptococcus suis","volume":"154","author":"M Esgleas","year":"2008","journal-title":"Microbiology"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1016\/j.vaccine.2012.02.075","article-title":"Ascaris suum enolase is a potential vaccine candidate against ascariasis","volume":"30","author":"N Chen","year":"2012","journal-title":"Vaccine"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1007\/s00436-010-1729-x","article-title":"Gan W, Zhao G, Xu H, Wu W, Du W, et al. Reverse vaccinology approach identify an Echinococcus granulosus tegumental membrane protein enolase as vaccine candidate","volume":"106","journal-title":"Parasitol Res"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0166-6851(99)00140-1","article-title":"Cloning and characterization of Leishmania mexicana fructose-1,6-bisphosphate aldolase","volume":"103","author":"S de Walque","year":"1999","journal-title":"Mol Biochem Parasitol"},{"key":"ref57","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1098\/rstb.1984.0111","article-title":"Mechanisms of acquired immunity in leishmaniasis","volume":"307","author":"JG Howard","year":"1984","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"4813","DOI":"10.1016\/j.vaccine.2008.06.102","article-title":"Induction of Th1-type cellular responses in cured\/exposed Leishmania-infected patients and hamsters against polyproteins of soluble Leishmania donovani promastigotes ranging from 89.9 to 97.1kDa","volume":"26","author":"S Kumari","year":"2008","journal-title":"Vaccine"},{"key":"ref59","unstructured":"Liew FY (1991) The effector mechanism and vaccination against cutaneous leishmaniasis. Behring Inst Mitt: 239\u2013243."},{"key":"ref60","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-2478(91)90024-5","article-title":"Role of cytokines in killing of intracellular pathogens","volume":"30","author":"FY Liew","year":"1991","journal-title":"Immunol Lett"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/eji.1830240328","article-title":"Production of nitric oxide and superoxide by activated macrophages and killing of Leishmania major","volume":"24","author":"J Assreuy","year":"1994","journal-title":"Eur J Immunol"},{"key":"ref62","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2249.2005.03000.x","article-title":"Identification of Leishmania donovani antigens stimulating cellular immune responses in exposed immune individuals","volume":"143","author":"P Tripathi","year":"2006","journal-title":"Clin Exp Immunol"},{"key":"ref63","doi-asserted-by":"crossref","first-page":"742","DOI":"10.4049\/jimmunol.146.2.742","article-title":"Characterization of a membrane antigen of Leishmania amazonensis that stimulates human immune responses","volume":"146","author":"JM Burns Jr","year":"1991","journal-title":"J Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"3575","DOI":"10.4049\/jimmunol.147.10.3575","article-title":"Human T cell responses to gp63, a surface antigen of Leishmania","volume":"147","author":"DM Russo","year":"1991","journal-title":"J Immunol"},{"key":"ref65","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/S0140-6736(00)03128-7","article-title":"Autoclaved Leishmania major vaccine for prevention of visceral leishmaniasis: a randomised, double-blind, BCG-controlled trial in Sudan","volume":"356","author":"EA Khalil","year":"2000","journal-title":"Lancet"},{"key":"ref66","doi-asserted-by":"crossref","first-page":"3485","DOI":"10.1016\/S0264-410X(01)00058-5","article-title":"Successful vaccination against Leishmania donovani infection in Indian langur using alum-precipitated autoclaved Leishmania major with BCG","volume":"19","author":"A Misra","year":"2001","journal-title":"Vaccine"},{"key":"ref67","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1016\/j.vaccine.2003.06.002","article-title":"Safety, immunogenecity, and efficacy of an autoclaved Leishmania amazonensis vaccine plus BCG adjuvant against New World cutaneous leishmaniasis","volume":"22","author":"RX Armijos","year":"2004","journal-title":"Vaccine"},{"key":"ref68","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1146\/annurev.immunol.15.1.323","article-title":"Nitric oxide and macrophage function","volume":"15","author":"J MacMicking","year":"1997","journal-title":"Annu Rev Immunol"},{"key":"ref69","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1128\/IAI.65.9.3644-3647.1997","article-title":"Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages","volume":"65","author":"Y Nozaki","year":"1997","journal-title":"Infect Immun"},{"key":"ref70","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1146\/annurev.iy.04.040186.002101","article-title":"Current status of immunological adjuvants","volume":"4","author":"HS Warren","year":"1986","journal-title":"Annu Rev Immunol"},{"key":"ref71","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1128\/IAI.66.1.18-27.1998","article-title":"Regional differences in the cellular immune response to experimental cutaneous or visceral infection with Leishmania donovani","volume":"66","author":"PC Melby","year":"1998","journal-title":"Infect Immun"},{"key":"ref72","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0769-2625(87)80036-3","article-title":"Identification of T-cell-reactive antigens that protect BALB\/c mice against Leishmania major","volume":"138","author":"P Scott","year":"1987","journal-title":"Ann Inst Pasteur Immunol"},{"key":"ref73","doi-asserted-by":"crossref","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"L Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"ref74","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.exppara.2005.11.005","article-title":"Leishmania major: species specific delayed hypersensitivity reaction induced by exogenous secreted antigen in the guinea pig","volume":"112","author":"AR Khabiri","year":"2006","journal-title":"Exp Parasitol"},{"key":"ref75","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s00436-006-0301-1","article-title":"Leishmania major: common antigen responsible for induction of delayed-type hypersensitivity response in guinea pigs","volume":"100","author":"AR Khabiri","year":"2007","journal-title":"Parasitol Res"},{"key":"ref76","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1146\/annurev.iy.07.040189.001045","article-title":"TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties","volume":"7","author":"TR Mosmann","year":"1989","journal-title":"Annu Rev Immunol"},{"key":"ref77","doi-asserted-by":"crossref","first-page":"10188","DOI":"10.1073\/pnas.90.21.10188","article-title":"Interleukin 12 acts directly on CD4+ T cells to enhance priming for interferon gamma production and diminishes interleukin 4 inhibition of such priming","volume":"90","author":"RA Seder","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref78","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/0169-4758(94)90162-7","article-title":"Parasites and T helper cell development: some insights","volume":"10","author":"SL Reiner","year":"1994","journal-title":"Parasitol Today"},{"key":"ref79","doi-asserted-by":"crossref","first-page":"4306","DOI":"10.4049\/jimmunol.145.12.4306","article-title":"Tumor necrosis factor-alpha synergizes with IFN-gamma in mediating killing of Leishmania major through the induction of nitric oxide","volume":"145","author":"FY Liew","year":"1990","journal-title":"J Immunol"},{"key":"ref80","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1084\/jem.172.5.1359","article-title":"A repetitive peptide of Leishmania can activate T helper type 2 cells and enhance disease progression","volume":"172","author":"FY Liew","year":"1990","journal-title":"J Exp Med"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1084\/jem.20030159","article-title":"Interleukin 1alpha promotes Th1 differentiation and inhibits disease progression in Leishmania major-susceptible BALB\/c mice","volume":"198","author":"E Von Stebut","year":"2003","journal-title":"J Exp Med"},{"key":"ref82","doi-asserted-by":"crossref","first-page":"3992","DOI":"10.4049\/jimmunol.168.8.3992","article-title":"CD8+ T cells are required for primary immunity in C57BL\/6 mice following low-dose, intradermal challenge with Leishmania major","volume":"168","author":"Y Belkaid","year":"2002","journal-title":"J Immunol"},{"key":"ref83","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1093\/infdis\/173.6.1515","article-title":"Interleukin-12 restores interferon-gamma production and cytotoxic responses in visceral leishmaniasis","volume":"173","author":"O Bacellar","year":"1996","journal-title":"J Infect Dis"},{"key":"ref84","doi-asserted-by":"crossref","first-page":"3091","DOI":"10.1128\/IAI.57.10.3091-3096.1989","article-title":"Comparison of T-cell responses in self-limiting versus progressive visceral Leishmania donovani infections in golden hamsters","volume":"57","author":"C Gifawesen","year":"1989","journal-title":"Infect Immun"},{"key":"ref85","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1086\/517817","article-title":"Splenic cytokine responses in Indian kala-azar before and after treatment","volume":"177","author":"RT Kenney","year":"1998","journal-title":"J Infect Dis"},{"key":"ref86","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1172\/JCI116570","article-title":"Interleukin 10 production correlates with pathology in human Leishmania donovani infections","volume":"92","author":"HW Ghalib","year":"1993","journal-title":"J Clin Invest"},{"key":"ref87","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/j.1365-3024.1992.tb00005.x","article-title":"Selective inability of spleen antigen presenting cells from Leishmania donovani infected hamsters to mediate specific T cell proliferation to parasite antigens","volume":"14","author":"V Rodrigues Junior","year":"1992","journal-title":"Parasite Immunol"},{"key":"ref88","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1089\/107999000312748","article-title":"The capacity to produce IFN-gamma rather than the presence of interleukin-4 determines the resistance and the degree of susceptibility to Leishmania donovani infection in mice","volume":"20","author":"J Lehmann","year":"2000","journal-title":"J Interferon Cytokine Res"},{"key":"ref89","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.immuni.2006.02.014","article-title":"IFN-gamma suppresses IL-10 production and synergizes with TLR2 by regulating GSK3 and CREB\/AP-1 proteins","volume":"24","author":"X Hu","year":"2006","journal-title":"Immunity"},{"key":"ref90","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/10408410591005101","article-title":"Macrophage and Leishmania: an unacceptable coexistence","volume":"31","author":"MK Basu","year":"2005","journal-title":"Crit Rev Microbiol"},{"key":"ref91","first-page":"318","article-title":"Serological investigations on Indian kala-azar","volume":"40","author":"AC Ghose","year":"1980","journal-title":"Clin Exp Immunol"},{"key":"ref92","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/0006-2952(87)90508-9","article-title":"Effects of methotrexate and other antifolates on the growth and dihydrofolate reductase activity of Leishmania promastigotes","volume":"36","author":"DA Scott","year":"1987","journal-title":"Biochem Pharmacol"},{"key":"ref93","unstructured":"Bretscher PA, Ogunremi O, Menon JN (1997) Distinct immunological states in murine cutaneous leishmaniasis by immunising with different amounts of antigen: the generation of beneficial, potentially harmful, harmful and potentially extremely harmful states. Behring Inst Mitt: 153\u2013159."},{"key":"ref94","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S0031182097002175","article-title":"Vaccination of langur monkeys (Presbytis entellus) against Leishmania donovani with autoclaved L. major plus BCG","volume":"3)","author":"A Dube","year":"1998","journal-title":"Parasitology 116 (Pt"},{"key":"ref95","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/S0264-410X(00)00398-4","article-title":"Immunisation with DNA encoding Leishmania infantum protein papLe22 decreases the frequency of parasitemic episodes in infected hamsters","volume":"19","author":"K Fragaki","year":"2001","journal-title":"Vaccine"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0086073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,10]],"date-time":"2023-07-10T01:24:13Z","timestamp":1688952253000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0086073"}},"subtitle":[],"editor":[{"given":"Patricia","family":"Talamas-Rohana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2014,1,24]]},"references-count":95,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,1,24]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0086073","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,1,24]]}}}